Evaluation of Prevent ID and Quantum Blue rapid tests for fecal calprotectin

Clinical Chemistry and Laboratory Medicine

Volumn 50, Issue 6, 2012, Pages 1079-1082

  Hessels, Jan ^a   Douw, Geke ^a   Yildirim, Duygu D ^a   Meerman, Gerrit ^a   Van Herwaarden, Margot A ^a   Van Den Bergh, Frank A J T M ^b  

^a DEVENTER HOSPITAL   (Netherlands)

^b MEDISCH SPECTRUM TWENTE   (Netherlands)

Author keywords

Calprotectin; Fecal; Rapid test; Time resolved fluorimetric immunoassay

Indexed keywords

CALGRANULIN;

ARTICLE; COLONOSCOPY; CONTROLLED STUDY; CORRELATION ANALYSIS; DIAGNOSTIC TEST ACCURACY STUDY; FECES ANALYSIS; FECES LEVEL; GASTROINTESTINAL SYMPTOM; GOLD STANDARD; HUMAN; IMMUNOASSAY; MAJOR CLINICAL STUDY; OUTPATIENT; PREDICTIVE VALUE; PREVENT ID CALDETECT RAPID TEST; PRIORITY JOURNAL; QUANTUM BLUE CALPROTECTIN RAPID TEST; SENSITIVITY AND SPECIFICITY; CHEMISTRY; CLINICAL CHEMISTRY; FECES; GASTROENTEROLOGY; METHODOLOGY; PATIENT REFERRAL; TIME;

CLINICAL CHEMISTRY TESTS; COLONOSCOPY; FECES; GASTROENTEROLOGY; HUMANS; LEUKOCYTE L1 ANTIGEN COMPLEX; REFERRAL AND CONSULTATION; TIME FACTORS;

EID: 84867406608     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/cclm-2011-0855     Document Type: Article

References (19)

1. Fagerhol MK, Andersson KB, Naess-Andresen CF, Braendtzaeg P, Dale I. Calprotectin (the L1 leukocyte protein). In: Smith VL, Dedman JR, editors, Stimulus response couling: the role of intracellular calcium binding-proteins. Boca Raton, FL: CRC Press; 1990:187-219.
2. Konikoff MR, Denson LA. Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. Inflamm Bowel Dis 2006;12:524-34.
3. Sutherland AD, Gearry RB, Frizelle FA. Review of fecal biomarkers in inflammatory bowel disease. Dis Colon Rectum 2008;51:1283-91.
4. Gisbert JP, McNicholl AG. Questions and answers on the role of faecal calprotectin as a biological marker in inflammatory bowel disease. Dig Liver Dis 2009;41:56-66.
5. Tibble JA, Sigthorsson G, Foster R, Forgacs I, Bjarnason I. Use of surrogate markers of inflammation and Rome criteria to distinguish organic from nonorganic intestinal disease. Gastroenterology 2002;123:450-60.
6. Røseth AG. Determination of faecal calprotectin, a novel marker of organic gastrointestinal disorders. Dig Liver Dis 2003;35:607-9.
7. Vermeire S, Van Assche G, Rutgeerts P. Laboratory markers in IBD: useful, magic, or unnecessary toys ? Gut 2006;55:426-31.
8. Meucci G, D'Incà R, Maieron R, Orzes N, Vecchi M, Visentini D, et al. Diagnostic value of faecal calprotectin in unselected outpatients referred for colonoscopy: a multicenter prospective study. Dig Liver Dis 2010;42:191-5.
9. Van Der Sluijs Veer G, Van Den Hoven B, Russel MG, Van Den Bergh FA. Time-resolved fluorimetric immunoassay of calprotectin: technical and clinical aspects in diagnosis of inflammatory bowel diseases. Clin Chem Lab Med 2006;44:292-8.
10. Vestergaard TA, Nielsen SL, Dahlerup JF, Hornung N. Fecal calprotectin: assessment of a rapid test. Scand J Clin Lab Invest 2008;68:343-7.
11. Damms A, Bischoff SC. Validation and clinical significance of a new calprotectin rapid test for the diagnosis of gastrointestinal diseases. Int J Colorectal Dis 2008;23:985-92.
12. Otten CM, Kok L, Witteman BJ, Baumgarten R, Kampman E, Moons KG, et al. Diagnostic performance of rapid tests for detection of fecal calprotectin and lactoferrin and their ability to discriminate inflammatory from irritable bowel syndrome. Clin Chem Lab Med 2008;46:1275-80.
13. Elkjaer M, Burisch J, Voxen Hansen V, Deibjerg Kristensen B, Slott Jensen JK, Munkholm P. A new rapid home test for fecal calprotectin in ulcerative colitis. Aliment Pharmacol Ther 2010;31:323-30.
14. Tøn H, Brandsnes DS, Holtlund J, Skuibina E, Schjønsby H, Johne B. Improved assay for fecal calprotectin. Clin Chim Acta 2000;292:41-54.
15. Van Den Bergh FA, Kolkman JJ, Russel MG, Vlaskamp RT, Vermes I. Calprotectine: een fecale marker voor diagnostiek en follow-up bij pati ë nten met chronische inflammatoire darmafwijkingen. Ned Tijdschr Geneeskd 2003;147:2360-5. [In Dutch].
16. Costa F, Mumolo MG, Ceccarelli L, Bellini M, Romano MR, Sterpi C, et al. Calprotectin is a stronger predictive marker of relapse in ulcerative colitis than in Crohn's disease. Gut 2005;54:364-8.
17. Sipponen T, Savilahti E, Kolho KL, Nuutinen H, Turunen U, Färkkilä M. Crohn's disease activity assessed by fecal calprotectin and lactoferrin: correlation with Crohn's disease activity index and endoscopic findings. Inflamm Bowel Dis 2008;14:40-6.
18. Gisbert JP, Bermejo F, Pérez-Calle JL, Taxonera C, Vera I, McNicholl AG, et al. Fecal calprotectin and lactoferrin for the prediction of inflammatory bowel disease relapse. Inflamm Bowel Dis 2009;15:1190-8.
19. Kallel L, Ayadi I, Matri S, Fekih M, Mahmoud NB, Feki M, et al. Fecal calprotectin is a predictive marker of relapse in Crohn's disease involving the colon: a prospective study. Eur J Gastroenterol Hepatol 2010;22:340-5.